Combined use of rare-earth element doped calcium carbonate particles with ultrasound for reducing local fat
US-2024165233-A1 · May 23, 2024 · US
US10322144B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10322144-B2 |
| Application number | US-201816015224-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 22, 2018 |
| Priority date | Jun 12, 2012 |
| Publication date | Jun 18, 2019 |
| Grant date | Jun 18, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An effervescent chewable dosage form that comprises a pH neutralization agent, an acid, and an effervescent agent. The chewable dosage form can also further comprise simethicone, a sweetener, and a lubricant. The pH neutralization agent can be calcium carbonate, the acid can be citric acid and the effervescent agent can be sodium bicarbonate.
Opening claim text (preview).
What is claimed is: 1. A method of providing heartburn relief comprising administering an effervescent chewable dosage form to a subject in need thereof, wherein the effervescent chewable dosage form comprises: a. from about 28% to about 34% of a pH neutralization agent; wherein the pH neutralization agent is calcium carbonate; b. from about 4% to about 6% of citric acid; c. from about 5% to about 7% of an effervescent agent; wherein the effervescent agent is sodium bicarbonate; d. from about 2% to about 9% of a gas reducer; wherein the gas reducer is simethicone; and e. from about 35% to about 50% of a nutritive sweetener; wherein the effervescent chewable dosage form is a tablet. 2. The method of providing heartburn relief of claim 1 wherein the effervescent chewable dosage form further comprises from about 0.05% to about 5% of a synthetic sweetener. 3. The method of providing heartburn relief of claim 1 wherein the effervescent chewable dosage form has a gas evolution of from about 24 mL to 32 mL. 4. The method of providing heartburn relief of claim 1 wherein the effervescent chewable dosage form further comprises starch. 5. The method of providing heartburn relief of claim 1 wherein the effervescent chewable dosage form has a tablet breaking force of about 3 kp to about 12 kp. 6. The method of providing heartburn relief of claim 1 wherein the effervescent chewable dosage form has a tablet breaking force of about 4 kp to about 8.5 kp. 7. The method of providing heartburn relief of claim 1 wherein the effervescent chewable dosage form has a molar ratio of effervescent agent to acid of from about 0.5:1 to about 6:1.
Silicon compounds · CPC title
Silicones; Polysiloxanes · CPC title
Organic compounds, e.g. phospholipids, fats · CPC title
Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin · CPC title
Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.